Global Biologics Safety Testing Service Supply, Demand and Key Producers, 2023-2029
The global Biologics Safety Testing Service market size is expected to reach $ 7743.3 million by 2029, rising at a market growth of 11.2% CAGR during the forecast period (2023-2029).
Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.
This report studies the global Biologics Safety Testing Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biologics Safety Testing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics Safety Testing Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biologics Safety Testing Service total market, 2018-2029, (USD Million)
Global Biologics Safety Testing Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biologics Safety Testing Service total market, key domestic companies and share, (USD Million)
Global Biologics Safety Testing Service revenue by player and market share 2018-2023, (USD Million)
Global Biologics Safety Testing Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Biologics Safety Testing Service total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biologics Safety Testing Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Charles River Laboratories, Sartorius, Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell and WuXi Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics Safety Testing Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biologics Safety Testing Service Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Biologics Safety Testing Service Market, Segmentation by Type
Raw Materials
Viral Banks
Cell Banks
Others
Global Biologics Safety Testing Service Market, Segmentation by Application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
Companies Profiled:
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
SGS
Q2 Solutions
Samsung Biologics
Texcell
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
CAS Testing Technical Services
NTEK
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
Key Questions Answered
1. How big is the global Biologics Safety Testing Service market?
2. What is the demand of the global Biologics Safety Testing Service market?
3. What is the year over year growth of the global Biologics Safety Testing Service market?
4. What is the total value of the global Biologics Safety Testing Service market?
5. Who are the major players in the global Biologics Safety Testing Service market?
6. What are the growth factors driving the market demand?